Acer Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAcer Therapeutics

Acer Therapeutics(ACER)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Olpruva	Phenylbutyrate	2022-12-22		Ornithine carbamoyltransferase deficiency disease , Carbamoyl-phosphate synthase i deficiency disease , Citrullinemia , Amyotrophic lateral sclerosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

alzheimer disease

,

central nervous system diseases

,

nervous system diseases

,

spinal cord diseases

,

tdp-43 proteinopathies

,

neuromuscular diseases

,

,

wolfram syndrome

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

neurodegenerative diseases

,

parkinsonian disorders

,

progressive supranuclear palsy

,

Sodium phenylbutyrate

,

myeloproliferative disorders

,

myelodysplastic-myeloproliferative diseases

,

intestinal neoplasms

,

color vision defects

,

parkinson disease

,

healthy volunteers/patients

,

,

inclusion body myositis

,

,

,

neurodevelopmental disorders

,

,

,

,

,

,

myelodysplastic syndromes

,

,

cystic fibrosis

,

,

muscular atrophy

,

spinal muscular atrophy

,

,

myeloid leukemia acute

,

myeloid leukemia

,

,

pulmonary tuberculosis

,

hepatic encephalopathy

,

pyruvate dehydrogenase complex deficiency disease

,

spinal muscular atrophies of childhood

,

inborn errors metabolism

,

inborn errors amino acid metabolism

,

brain neoplasms

,

inborn errors lipid metabolism

,

multiple acyl coenzyme a dehydrogenase deficiency

,

prostatic neoplasms

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

beta-thalassemia

,

,

,

acquired immunodeficiency syndrome

,

liver cirrhosis

,

stomach neoplasms

,

head and neck neoplasms

,

lymphoproliferative disorders

,

epstein-barr virus infections

,

argininosuccinic aciduria

,

,

mucinous adenocarcinoma

,

colonic neoplasms

,

,

rectal neoplasms

,

cystadenocarcinoma

,

alzheimer disease

,

central nervous system diseases

,

nervous system diseases

,

spinal cord diseases

,

tdp-43 proteinopathies

,

neuromuscular diseases

,

,

spinocerebellar degenerations

,

spinocerebellar ataxias

,

machado-joseph disease

,

cerebellar ataxia

,

huntington disease

,

corticobasal degeneration

,

wolfram syndrome

,

deficiency diseases

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

intrahepatic cholestasis

,

neurodegenerative diseases

,

inborn genetic diseases

,

,

maple syrup urine disease

,

,

parkinsonian disorders

,

progressive supranuclear palsy

,

,

inborn urea cycle disorders

,

diabetes mellitus

,

insulin resistance

,

type 2 diabetes mellitus

,

postoperative complications

,

cardiac arrhythmias

,

ehlers-danlos syndrome

,

,

type iv ehlers-danlos syndrome

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

williams syndrome

multiple sclerosis

,

multiple sclerosis

,

disease progression

,

neoplasm metastasis

,

autoimmune diseases

,

nervous system diseases

,

autoimmune diseases of the nervous system

,

chronic progressive multiple sclerosis

,

Phenylbutanoic acid

inborn errors lipid metabolism

,

multiple acyl coenzyme a dehydrogenase deficiency

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use